General Newsroom Hero 1920x480 (4:1)
Our Work

Latham & Watkins Advises Novo Holdings on Quanta’s US$245 Million Series D Fundraising

June 24, 2021
London corporate team counsels on largest-ever private funding round for a dialysis device company.

Latham & Watkins advised Novo Holdings on co-leading a US$245 Million Series D funding round for Quanta Dialysis Technologies, a medical technology leader delivering on its vision for more flexible and accessible dialysis care.

The round was co-led by hedge fund Glenview Capital, with support from a broad group of other top-tier investors, including BlackRock, Eldridge, Sands Capital, Millennium, Monashee Investment Management LLC., Puhua Capital, Segulah Medical and Ancora, alongside Orlando Health, an integrated delivery network. Existing shareholders also participated in the round, including Wellington Partners, btov, Seroba and The Grands.

The Latham team was led by London corporate partner Robbie McLaren, with associate Samantha Peacock. Advice on life science matters by was provided by associates Frances Stocks Allen, Sara Patel, and Oscar Bjartell; and on employment matters by associates Adam Ray and Kendall Burnett. 


    Related Capabilities